Apoptosis: Activate NF-κB or die?

Current Biology

Volumn 7, Issue 2, 1997, Pages

  Baichwal, Vijay R ^a   Baeuerle, Patrick A ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; GLUTAMIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR;

ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; DRUG EFFECT; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; GLUTAMIC ACID; HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 0030898311     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0960-9822(06)00046-7     Document Type: Article

References (15)

1. Baeuerle PA, Henkel T: Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994, 12:141-179.
2. Beg AA, Baltimore D: An essential role for NF-κB in preventing TNF-α-induced cell death. Science 1996, 274:782-784.
3. Wang C-Y, Mayo MW, Baldwin AS Jr: TNF- and cancer therapy-induced apoptosis: potentiation by inhibition of NF- κB. Science 1996, 274:784-787.
4. van Antwerp DJ, Martin SJ, Kafri T, Green D, Verma IM: Suppression of TNF-á -induced apoptosis by NF-κB. Science 1996, 274:787-789.
5. Liu Z-G, Hsu H, Goeddel D, Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 1996, 87:565-576.
6. Wu M, Lee H, Bellas RE, Schauer SL, Arsura M, Katz D, FitzGerald MJ, Rothstein TL, Sherr DH, Sonenshein GE: Inhibition of NF-κB/Rel induces apoptosis of murine B cells. EMBO J 1996, 15:4682-4690.
7. Fraser A, Evan G: A license to kill. Cell 1996, 85:781-784.
8. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D: Embryonic lethality and liver degeneration in mice lacking the ReIA component of NF-κB. Nature 1995, 376:167-170.
9. Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM: The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 1992, 267:12424-12427.
10. Wong GH, Elwell JH, Oberley LW, Goeddel DV: Manganous Superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 1989, 58:923-931.
11. Grilli M, Pizzi M, Memo M, Spano PF: Neuroprotection by aspirin and sodium salicylate through blockade of NF-κB activation. Science 1996, 274:1383-1385.
12. Carter BD, Kaltschimdt C, Kaltschimdt B, Offenhauser N, Bohm-Matthaei, Baeuerle PA, Barde Y-A: Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science 1996, 272:542-545.
13. Grimm S, Bauer MKA, Baeuerle PA, Schulze-Osthoff K: Bcl-2 down-regulates the activity of transcription factor NF-κB induced upon apoptosis. J Cell Biol 1996, 134:13-23.
14. Lin K-I, Lee S-H, Narayanan R, Baraban JM, Hardwick JM, Ratan RR: Thiol agents and bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-κB. J Cell Biol 1995, 131:1149-1161.
15. Baeuerle PA, Baichwal VR: NF-κB as a frequent target for immunosuppressive and anti- inflammatory molecules. Adv Immunol 1997, in press.